Suppr超能文献

[结核分枝杆菌及L型耐药性的临床意义]

[Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].

作者信息

Golanov V S, Bogdalova V E, Andreev L P, Losin E I, Ushakova A G, Meshcheriakov V G, Bondin S V

出版信息

Probl Tuberk. 1991(12):27-8.

PMID:1803368
Abstract

The clinical features of a tuberculous process were studied in 101 patients with active pulmonary tuberculosis among whom 76% of the patients lost their social adaptation. The patients were divided into 2 groups: group 1 comprising 61 (60.4%) subjects who excreted tuberculosis mycobacteria and L-forms and group 2 consisting of 40 (39.6%) who excreted only tuberculosis mycobacteria. The frequency and degree of drug resistance were more manifest in 63.8% of the patients of group 1 and in 40% of those of group 2 (p less than 0.01). Drug resistance to relatively new antituberculosis drugs (ethambutol and rifampicin) was found in 30% of the patients. Mixed bacillary population was found 2 times more frequently in patients with serious progressive forms of tuberculosis, which gives evidence to consider it as a prognostically unfavourable indicator.

摘要

对101例活动性肺结核患者的结核病程临床特征进行了研究,其中76%的患者失去了社会适应能力。患者被分为两组:第一组有61例(60.4%)排出结核分枝杆菌和L型菌,第二组有40例(39.6%)仅排出结核分枝杆菌。第一组63.8%的患者和第二组40%的患者耐药频率和程度更为明显(p<0.01)。30%的患者对相对较新的抗结核药物(乙胺丁醇和利福平)耐药。在严重进展型肺结核患者中,混合菌种群的发现频率高出两倍,这证明将其视为预后不良指标是合理的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验